These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
222 related items for PubMed ID: 23670031
1. Traumatic intracranial hemorrhage in patients taking dabigatran: report of 3 cases and review of the literature. Wassef SN, Abel TJ, Grossbach A, Viljoen SV, Jackson AW, Howard MA, Greenlee JD. Neurosurgery; 2013 Aug; 73(2):E368-73; discussion E373-4. PubMed ID: 23670031 [Abstract] [Full Text] [Related]
2. Hemorrhagic complications in emergency department patients who are receiving dabigatran compared with warfarin. Berger R, Salhanick SD, Chase M, Ganetsky M. Ann Emerg Med; 2013 Apr; 61(4):475-9. PubMed ID: 23522810 [Abstract] [Full Text] [Related]
3. Bleeding events among new starters and switchers to dabigatran compared with warfarin in atrial fibrillation. Larsen TB, Gorst-Rasmussen A, Rasmussen LH, Skjøth F, Rosenzweig M, Lip GY. Am J Med; 2014 Jul; 127(7):650-656.e5. PubMed ID: 24530792 [Abstract] [Full Text] [Related]
4. Dabigatran and factor Xa inhibitors for stroke prevention in patients with nonvalvular atrial fibrillation. Uchiyama S, Ibayashi S, Matsumoto M, Nagao T, Nagata K, Nakagawara J, Tanahashi N, Tanaka K, Toyoda K, Yasaka M. J Stroke Cerebrovasc Dis; 2012 Apr; 21(3):165-73. PubMed ID: 22440950 [Abstract] [Full Text] [Related]
5. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation. Freeman JV, Zhu RP, Owens DK, Garber AM, Hutton DW, Go AS, Wang PJ, Turakhia MP. Ann Intern Med; 2011 Jan 04; 154(1):1-11. PubMed ID: 21041570 [Abstract] [Full Text] [Related]
6. Intracranial hemorrhage during dabigatran treatment. Komori M, Yasaka M, Kokuba K, Matsuoka H, Fujimoto S, Yoshida M, Kameda K, Shono T, Nagata S, Ago T, Kitazono T, Okada Y. Circ J; 2014 Jan 04; 78(6):1335-41. PubMed ID: 24662438 [Abstract] [Full Text] [Related]
7. Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial. Hart RG, Diener HC, Yang S, Connolly SJ, Wallentin L, Reilly PA, Ezekowitz MD, Yusuf S. Stroke; 2012 Jun 04; 43(6):1511-7. PubMed ID: 22492518 [Abstract] [Full Text] [Related]
8. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation. Mantha S, Ansell J. Thromb Haemost; 2012 Sep 04; 108(3):476-84. PubMed ID: 22740145 [Abstract] [Full Text] [Related]
9. Bleeding rates in Veterans Affairs patients with atrial fibrillation who switch from warfarin to dabigatran. Vaughan Sarrazin MS, Jones M, Mazur A, Chrischilles E, Cram P. Am J Med; 2014 Dec 04; 127(12):1179-85. PubMed ID: 25107386 [Abstract] [Full Text] [Related]
10. Removal of dabigatran by hemodialysis. Chang DN, Dager WE, Chin AI. Am J Kidney Dis; 2013 Mar 04; 61(3):487-9. PubMed ID: 23219111 [Abstract] [Full Text] [Related]
11. Dabigatran for stroke prevention in atrial fibrillation. Hohnloser SH, Diener HC. Hamostaseologie; 2012 Mar 04; 32(3):216-20. PubMed ID: 22739760 [Abstract] [Full Text] [Related]
12. Dabigatran bleed risk with closed head injuries: are we prepared? Parra MW, Zucker L, Johnson ES, Gullett D, Avila C, Wichner ZA, Kokaram CR. J Neurosurg; 2013 Sep 04; 119(3):760-5. PubMed ID: 23634730 [Abstract] [Full Text] [Related]
13. Management of dabigatran-associated intracerebral and intraventricular hemorrhage: a case report. Faust AC, Peterson EJ. J Emerg Med; 2014 Apr 04; 46(4):525-9. PubMed ID: 24508114 [Abstract] [Full Text] [Related]
14. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial. Eikelboom JW, Wallentin L, Connolly SJ, Ezekowitz M, Healey JS, Oldgren J, Yang S, Alings M, Kaatz S, Hohnloser SH, Diener HC, Franzosi MG, Huber K, Reilly P, Varrone J, Yusuf S. Circulation; 2011 May 31; 123(21):2363-72. PubMed ID: 21576658 [Abstract] [Full Text] [Related]
15. Modeling of the impact on health outcomes of the use of dabigatran in patients with atrial fibrillation. Chevalier J, Giroud M, de Pouvourville G. Cerebrovasc Dis; 2013 May 31; 35(4):320-6. PubMed ID: 23615428 [Abstract] [Full Text] [Related]
16. The importance of postapproval data for dabigatran. Redberg RF. JAMA Intern Med; 2015 Jan 31; 175(1):25. PubMed ID: 25365377 [No Abstract] [Full Text] [Related]
17. The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study. Connolly SJ, Wallentin L, Ezekowitz MD, Eikelboom J, Oldgren J, Reilly PA, Brueckmann M, Pogue J, Alings M, Amerena JV, Avezum A, Baumgartner I, Budaj AJ, Chen JH, Dans AL, Darius H, Di Pasquale G, Ferreira J, Flaker GC, Flather MD, Franzosi MG, Golitsyn SP, Halon DA, Heidbuchel H, Hohnloser SH, Huber K, Jansky P, Kamensky G, Keltai M, Kim SS, Lau CP, Le Heuzey JY, Lewis BS, Liu L, Nanas J, Omar R, Pais P, Pedersen KE, Piegas LS, Raev D, Smith PJ, Talajic M, Tan RS, Tanomsup S, Toivonen L, Vinereanu D, Xavier D, Zhu J, Wang SQ, Duffy CO, Themeles E, Yusuf S. Circulation; 2013 Jul 16; 128(3):237-43. PubMed ID: 23770747 [Abstract] [Full Text] [Related]
18. Neurosurgical complications of direct thrombin inhibitors--catastrophic hemorrhage after mild traumatic brain injury in a patient receiving dabigatran. Garber ST, Sivakumar W, Schmidt RH. J Neurosurg; 2012 May 16; 116(5):1093-6. PubMed ID: 22394293 [Abstract] [Full Text] [Related]
19. Stroke prophylaxis with warfarin or dabigatran for patients with non-valvular atrial fibrillation-cost analysis. Ali A, Bailey C, Abdelhafiz AH. Age Ageing; 2012 Sep 16; 41(5):681-4. PubMed ID: 22378612 [Abstract] [Full Text] [Related]
20. [Patient with acute renal injury presenting dabigatran overdose: Hemodialysis for surgery]. Bachellerie B, Ruiz S, Conil JM, Crognier L, Seguin T, Georges B, Fourcade O. Ann Fr Anesth Reanim; 2014 Jan 16; 33(1):44-6. PubMed ID: 24378048 [Abstract] [Full Text] [Related] Page: [Next] [New Search]